Pfizer Strikes Multibillion-Dollar Deal to Take on Autoimmune Diseases
Source: Benzinga ·

Pfizer Inc. (NYSE:PFE) announced Wednesday an exclusive licensing agreement with Starna Therapeutics worth up to $2.63 billion in upfront and milestone payments, plus royalties. The agreement expands Pfizer’s inflammation and immunology pipeline while strengthening its presence i
Read the full story at Benzinga
Shared from the GodsView world desk: live wires next to a globe of flights, ships, fires, and quakes.